Nifty
Sensex
:
:
23250.10
76295.36
-82.25 (-0.35%)
-322.08 (-0.42%)

Healthcare Services - Diagnostic

Rating :
N/A

BSE: 542650 | NSE: METROPOLIS

1851.95
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1814.00
  •  1875.00
  •  1811.25
  •  1805.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  354675
  •  6584.65
  •  2318.30
  •  1502.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,121.90
  • 52.34
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,067.55
  • 0.25%
  • 6.56

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 49.40%
  • 0.20%
  • 3.34%
  • FII
  • DII
  • Others
  • 16.73%
  • 29.87%
  • 0.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.26
  • 7.12
  • -0.56

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.38
  • 3.96
  • -3.59

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.69
  • 0.68
  • -15.81

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 60.84
  • 53.45

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 11.76
  • 8.29

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 32.16
  • 27.22

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
24.95
34.68
43.73
52.01
P/E Ratio
86.89
62.52
49.57
41.68
Revenue
1208
1362
1548
1755
EBITDA
283
346
408
471
Net Income
128
178
225
271
ROA
8.4
10.7
12.6
14
P/B Ratio
10.13
9.05
7.98
7.09
ROE
12.26
15.63
17.51
18.57
FCFF
210.28
205.76
249.4
299.56
FCFF Yield
1.89
1.85
2.24
2.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
322.77
291.12
10.87%
349.79
308.50
13.38%
313.36
277.09
13.09%
331.00
282.55
17.15%
Expenses
250.76
226.27
10.82%
259.91
233.69
11.22%
234.54
214.15
9.52%
251.02
212.26
18.26%
EBITDA
72.01
64.85
11.04%
89.88
74.81
20.14%
78.81
62.94
25.21%
79.98
70.29
13.79%
EBIDTM
22.31%
22.28%
25.69%
24.25%
25.15%
22.71%
24.16%
24.88%
Other Income
2.56
2.31
10.82%
3.13
1.22
156.56%
2.46
3.05
-19.34%
2.54
1.23
106.50%
Interest
4.53
5.31
-14.69%
4.79
5.68
-15.67%
4.65
5.98
-22.24%
5.57
6.17
-9.72%
Depreciation
27.70
24.99
10.84%
26.82
22.24
20.59%
25.54
20.82
22.67%
26.42
23.43
12.76%
PBT
42.34
36.86
14.87%
61.40
48.11
27.62%
51.08
39.19
30.34%
50.53
41.90
20.60%
Tax
10.86
9.57
13.48%
14.70
12.45
18.07%
12.97
10.21
27.03%
14.01
8.41
66.59%
PAT
31.47
27.29
15.32%
46.70
35.66
30.96%
38.11
28.98
31.50%
36.52
33.49
9.05%
PATM
9.75%
9.37%
13.35%
11.56%
12.16%
10.46%
11.03%
11.85%
EPS
6.12
5.30
15.47%
9.08
6.92
31.21%
7.41
5.62
31.85%
7.11
6.51
9.22%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,316.92
1,207.71
1,148.21
1,228.34
997.99
856.41
761.18
647.16
544.72
524.02
454.72
Net Sales Growth
13.60%
5.18%
-6.52%
23.08%
16.53%
12.51%
17.62%
18.81%
3.95%
15.24%
 
Cost Of Goods Sold
264.26
242.57
253.26
276.02
252.16
204.13
173.51
145.90
135.10
143.33
129.21
Gross Profit
1,052.66
965.14
894.95
952.31
745.82
652.27
587.67
501.27
409.62
380.69
325.51
GP Margin
79.93%
79.91%
77.94%
77.53%
74.73%
76.16%
77.21%
77.46%
75.20%
72.65%
71.58%
Total Expenditure
996.23
919.78
857.10
882.67
708.20
619.27
557.23
468.69
391.23
387.93
337.21
Power & Fuel Cost
-
16.20
14.43
14.73
12.00
12.49
11.00
9.99
9.12
9.03
8.15
% Of Sales
-
1.34%
1.26%
1.20%
1.20%
1.46%
1.45%
1.54%
1.67%
1.72%
1.79%
Employee Cost
-
275.78
252.73
233.17
198.64
190.16
176.21
147.37
127.69
115.71
94.91
% Of Sales
-
22.83%
22.01%
18.98%
19.90%
22.20%
23.15%
22.77%
23.44%
22.08%
20.87%
Manufacturing Exp.
-
46.05
31.30
48.35
34.23
22.51
19.24
18.84
10.86
8.93
13.26
% Of Sales
-
3.81%
2.73%
3.94%
3.43%
2.63%
2.53%
2.91%
1.99%
1.70%
2.92%
General & Admin Exp.
-
307.81
289.77
300.57
177.98
167.62
166.23
132.17
101.87
101.19
85.00
% Of Sales
-
25.49%
25.24%
24.47%
17.83%
19.57%
21.84%
20.42%
18.70%
19.31%
18.69%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
31.37
15.60
9.83
33.19
22.37
11.03
14.43
6.59
9.74
0.00
% Of Sales
-
2.60%
1.36%
0.80%
3.33%
2.61%
1.45%
2.23%
1.21%
1.86%
1.47%
EBITDA
320.68
287.93
291.11
345.67
289.79
237.14
203.95
178.47
153.49
136.09
117.51
EBITDA Margin
24.35%
23.84%
25.35%
28.14%
29.04%
27.69%
26.79%
27.58%
28.18%
25.97%
25.84%
Other Income
10.69
9.12
17.46
20.03
12.05
8.57
8.21
7.77
25.59
21.80
6.01
Interest
19.54
27.89
31.85
25.02
11.56
12.65
4.12
3.54
1.94
1.62
2.16
Depreciation
106.48
94.47
89.22
63.22
45.94
39.27
20.07
19.02
17.23
20.54
20.52
PBT
205.35
174.69
187.50
277.45
244.32
193.78
187.98
163.68
159.92
135.73
100.84
Tax
52.54
46.23
44.11
78.67
60.97
41.18
62.94
51.84
52.66
46.09
33.04
Tax Rate
25.59%
26.46%
23.53%
26.82%
24.95%
24.33%
33.48%
31.67%
32.93%
36.00%
32.76%
PAT
152.80
127.82
142.88
214.19
183.10
127.84
121.58
104.23
107.26
73.62
60.93
PAT before Minority Interest
152.23
128.46
143.39
214.69
183.35
128.07
125.04
111.84
107.26
81.93
67.80
Minority Interest
-0.57
-0.64
-0.51
-0.50
-0.25
-0.23
-3.46
-7.61
0.00
-8.31
-6.87
PAT Margin
11.60%
10.58%
12.44%
17.44%
18.35%
14.93%
15.97%
16.11%
19.69%
14.05%
13.40%
PAT Growth
21.83%
-10.54%
-33.29%
16.98%
43.23%
5.15%
16.65%
-2.82%
45.69%
20.83%
 
EPS
29.79
24.92
27.85
41.75
35.69
24.92
23.70
20.32
20.91
14.35
11.88

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,096.16
988.23
886.20
706.60
523.50
418.54
414.77
323.17
265.00
361.28
Share Capital
10.25
10.24
10.23
10.22
10.13
10.04
9.54
9.54
9.54
9.86
Total Reserves
1,078.18
970.64
864.17
687.85
511.30
405.91
403.52
313.58
255.45
351.42
Non-Current Liabilities
373.45
416.66
492.88
110.93
194.63
141.74
147.66
15.72
1.06
9.51
Secured Loans
0.00
28.61
158.68
0.00
0.00
0.04
0.20
0.36
0.46
3.66
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.78
3.57
Long Term Provisions
186.97
190.65
173.80
43.70
156.34
140.38
145.88
3.15
3.01
3.03
Current Liabilities
275.48
302.83
363.85
240.17
210.20
241.37
232.97
151.85
105.02
74.95
Trade Payables
99.44
94.08
103.21
110.56
85.03
42.85
35.34
35.91
38.13
34.15
Other Current Liabilities
119.68
101.52
84.26
73.22
74.11
49.87
42.42
102.44
38.25
34.90
Short Term Borrowings
0.00
50.44
99.87
0.00
0.00
17.58
0.37
0.40
0.19
0.19
Short Term Provisions
56.35
56.80
76.52
56.40
51.05
131.07
154.84
13.11
28.44
5.71
Total Liabilities
1,748.21
1,710.20
1,744.90
1,059.16
929.99
803.08
809.77
511.72
391.34
468.31
Net Block
1,177.06
1,120.67
1,058.93
343.11
296.37
212.81
207.44
202.35
147.67
152.75
Gross Block
1,493.43
1,344.29
1,223.49
438.35
366.11
271.30
246.45
219.74
272.76
260.03
Accumulated Depreciation
316.37
223.63
164.56
95.24
69.74
58.49
39.01
17.38
125.08
107.28
Non Current Assets
1,402.77
1,369.61
1,289.47
414.50
492.20
381.48
367.09
226.61
165.87
166.72
Capital Work in Progress
0.00
19.51
5.78
0.00
2.99
5.77
0.00
0.95
0.56
0.36
Non Current Investment
1.75
1.75
1.75
1.75
1.75
2.27
1.76
7.79
1.76
3.05
Long Term Loans & Adv.
218.73
226.36
206.61
67.91
179.09
150.19
149.29
13.09
15.84
10.43
Other Non Current Assets
5.23
1.32
16.40
1.73
12.00
10.43
8.61
2.43
0.04
0.12
Current Assets
345.43
340.60
455.42
644.68
437.78
421.60
442.67
285.12
225.47
301.59
Current Investments
53.07
13.06
13.75
8.33
12.57
31.02
100.42
134.05
78.68
166.60
Inventories
38.69
44.59
51.11
40.55
24.40
26.10
21.19
14.13
17.62
18.33
Sundry Debtors
126.28
121.89
135.49
122.98
128.25
136.85
100.68
80.29
77.14
76.12
Cash & Bank
71.22
93.19
166.94
419.70
210.47
80.24
60.14
40.51
43.12
29.06
Other Current Assets
56.16
9.39
9.81
3.12
62.10
147.40
160.24
16.14
8.89
11.48
Short Term Loans & Adv.
48.71
58.48
78.33
50.00
57.46
135.02
155.50
12.14
6.29
9.24
Net Current Assets
69.96
37.76
91.57
404.50
227.58
180.24
209.70
133.26
120.45
226.64
Total Assets
1,748.20
1,710.21
1,744.89
1,059.18
929.98
803.08
809.76
511.73
391.34
468.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
264.07
247.09
253.27
249.03
215.00
90.15
103.93
101.75
PBT
174.69
187.50
293.35
244.32
168.73
186.55
163.68
159.92
Adjustment
121.31
104.06
58.83
76.84
82.72
21.78
20.75
-3.00
Changes in Working Capital
5.45
7.11
-16.40
-15.31
27.97
-50.78
-22.92
-3.90
Cash after chg. in Working capital
301.45
298.67
335.79
305.86
279.43
157.55
161.51
153.02
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-37.38
-51.58
-82.51
-56.83
-64.43
-67.40
-57.57
-51.27
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-89.41
46.79
-737.57
61.70
-104.83
35.34
1.88
-85.78
Net Fixed Assets
-125.54
-130.27
-773.59
-124.37
-58.07
-24.62
-32.97
Net Investments
-40.01
0.69
-38.53
117.91
5.31
-37.07
40.96
Others
76.14
176.37
74.55
68.16
-52.07
97.03
-6.11
Cash from Financing Activity
-181.20
-292.33
162.52
-32.69
-55.32
-118.15
-87.30
-17.30
Net Cash Inflow / Outflow
-6.54
1.56
-321.78
278.04
54.85
7.35
18.51
-1.33
Opening Cash & Equivalents
68.83
65.98
386.59
107.17
51.37
43.47
25.51
26.83
Closing Cash & Equivalent
62.62
68.83
65.98
386.59
107.17
51.37
43.47
25.51

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
212.47
191.54
170.88
136.57
102.99
82.89
432.82
338.57
277.67
366.26
ROA
7.43%
8.30%
15.31%
18.43%
14.78%
15.51%
16.93%
23.75%
19.06%
14.48%
ROE
12.42%
15.46%
27.31%
30.07%
27.33%
30.17%
30.38%
36.47%
26.16%
18.77%
ROCE
18.73%
19.83%
34.39%
41.60%
37.90%
45.10%
45.22%
54.28%
40.06%
27.47%
Fixed Asset Turnover
0.85
0.89
1.48
2.48
2.69
2.94
2.78
2.21
1.97
1.75
Receivable days
37.50
40.91
38.40
45.94
56.49
56.95
51.03
52.74
53.38
61.10
Inventory Days
12.59
15.21
13.62
11.88
10.76
11.34
9.96
10.64
12.52
14.71
Payable days
145.60
142.17
141.34
141.56
49.58
35.51
37.97
44.90
44.18
46.13
Cash Conversion Cycle
-95.51
-86.05
-89.32
-83.74
17.67
32.78
23.02
18.48
21.71
29.69
Total Debt/Equity
0.00
0.08
0.30
0.00
0.00
0.04
0.00
0.00
0.03
0.04
Interest Cover
7.26
6.89
12.72
22.13
14.38
46.64
47.17
83.60
80.00
47.64

News Update:


  • Metropolis Healthcare acquires Core Diagnostics
    24th Mar 2025, 14:41 PM

    Core Diagnostics becomes a wholly owned subsidiary of the company

    Read More
  • Metropolis Healthcare’s arm to acquire Agra-based Scientific Pathology
    3rd Mar 2025, 14:29 PM

    This strategic move strengthens Metropolis’ presence in Western Uttar Pradesh, accelerates its B2C expansion, and unlocks growth opportunities across the state and beyond

    Read More
  • Metropolis Health. - Quarterly Results
    4th Feb 2025, 17:55 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.